Ads
related to: liver disease- Request A Rep
Get In Touch For More Info
Or Request To Speak To A Rep.
- View Safety & Efficacy
Learn About The Primary Endpoint
And Data For The Treatment Of HRS.
- HRS Dosing Information
Visit The Site To Learn About HRS
Recommended Dosing & Management.
- Download Resources
Discover & Download HRS
Resources On The Website.
- Request A Rep
Search results
Earnings call: Gilead reports robust Q1 growth, Trodelvy drives sales By Investing.com
Investing.com· 10 hours agoThe company's HIV product sales saw a 4% rise, while oncology product sales surged by 18%, primarily...
Jacksonville psychologist: Alcohol-related health problems rising among women
The Florida Times-Union via Yahoo News· 2 days agoA new study published in this month’s Journal of the American Medical Association shows rising...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 3 hours agoRobbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Akero Therapeutics, Inc. (NASDAQ: AKRO) securities ...
Wait, Does Drinking Lemon Water Actually Help You Lose Weight?
Men's Health via AOL· 4 days agoThe truth about whether lemon water—hot or cold—can help you drop pounds if you drink it 30 minutes...
Gut microbes that get you drunk and damage your liver − how the microbiome can create a microbrewery
San Francisco Chronicle· 4 days agoPeople with this syndrome carry microbes in their intestines that produce abnormally high levels of alcohol when breaking down sugars and carbohydrates. It turns out the specific species of ...
Gilead Sciences Inc (GILD) Q1 2024 Earnings: Misses Analyst EPS Estimates Amid Significant ...
GuruFocus.com via Yahoo Finance· 4 days agoTotal Revenue: Reached $6.7 billion in Q1 2024, a 5% increase year-over-year, exceeding estimates of...
Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 4 days agoImage source: The Motley Fool. Gilead Sciences (NASDAQ: GILD) Q1 2024 Earnings Call Apr 25, 2024,...
Gilead stock gains on revenue beat, despite a quarterly loss By Investing.com
Investing.com· 4 days agoGilead Sciences, Inc. (NASDAQ:GILD) has reported a revenue increase in its first quarter of 2024,...
Gilead's quarterly loss is narrower than expected
Morningstar· 4 days agoGilead Sciences Inc.'s stock dipped 0.2% in after-hours trading Thursday, after the drug company's adjusted first-quarter profit was narrower than expected. Gilead (GILD) posted a net loss of ...
Four red flag signs of silent killer one in three Brits at risk of having
Daily Express· 7 days agoThe liver is one of our vital organs that performs hundreds of important functions for the body. In...
